Sjogren's Syndrome

New Classification Criteria for Sjogren's syndrome

November 09, 2016

The American College of Rheumatology and the European League Against Rheumatism have published an international set of classification criteria for primary Sjögren's syndrome.

Rheumatic IRAEs in Cancer Patients Treated with ICIs

September 28, 2016

The Rheumatology Journal Club resumes its Twitter chat series this week with a focus on rheumatological immune-related adverse events in immunotherapy.

Neurological Signs in Sjogren’s Too Often Ignored

April 25, 2016

Clinicians should pay more attention to neurological signs in patients with high-activity primary Sjogren’s Syndrome or those with prior neurological involvements.

Carbamylated Proteins as a Biomarker for Sjogren’s Syndrome

September 16, 2015

Autoantibodies against carbamylated proteins in Sjögren’s syndrome could be used as a new biomarker.

Sjögren’s Patients Could Benefit from Lupus Drug

August 19, 2015

B-cells that are active in lupus may also play a role in Sjögren’s syndrome. A new study finds that the same B-cell depleter drug, belimumab (Benlysta) approved for lupus, may also benefit Sjögren’s patients.

Free For All: Rheumatology Textbook by Cush, Kavanaugh, and Stein

April 02, 2015

Three eminent rheumatologists have posted their comprehensive textbook of rheumatology online, open-access and free. They are calling it Rheumaknowledgy.

Post-Op VTE Risk in Rheumatic Disease Traces to Clotting Issues

March 26, 2015

The increased risk for venous thromoboembolism after surgery among patients with rheumatic disease appears to trace to those conditions with a clotting component. However, joint surgery in general has a high risk of this complication.

Good News for Community Rheumatologists: Your Own Research Grant

March 11, 2015

A Miami rheumatologist tells why he has donated $1 million to offer his colleagues in community practice the chance to pursue their own clinical theories.

IgG Patterns Suggest Autoimmune Changes in SSc, SLE, Sjögren's

January 20, 2015

IgG4 levels were low in this study for only systemic sclerosis and Sjögren's. But other patterns suggested aberrant immune regulation.

For Better Medication Outcomes, Help Patients Do the Math?

December 16, 2014

Can you guess what proportion of patients in private rheumatology practices can't follow instructions for taking methotrexate? The authors of this study offer some suggestions to improve adherence.